| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Naproxen sodium (substance) |
Is a |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen measurement |
Component |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen poisoning |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental naproxen poisoning |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional naproxen poisoning |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par le naproxène d'intention indéterminée |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen adverse reaction |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to naproxen (finding) |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen overdose |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental naproxen overdose |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional naproxen overdose |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de naproxène d'intention indéterminée |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 250 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 375mg e/c tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 500 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 500mg tablet and misoprostol 200micrograms tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing misoprostol and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lansoprazole- and naproxen-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lansoprazole 15mg m/r capsule/naproxen 375mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lansoprazole 15mg m/r capsule/naproxen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing naproxen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen sodium 220mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to naproxen |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 500 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aleve 200mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional naproxen poisoning |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 200mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lansoprazole 15mg m/r capsule/naproxen 250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental poisoning by naproxen |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Esomeprazole magnesium 20mg + naproxen 375mg delayed release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Esomeprazole magnesium 20mg + naproxen 500mg delayed release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing esomeprazole magnesium and naproxen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to naproxen (finding) |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 200 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen sodium (substance) |
Is modification of (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 200mg/pseudoephedrine 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naproxen 500 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 500 mg rectal suppository |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 250 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 250 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 500 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 500 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 200 mg oral capsule |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing naproxen and sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen- and sumatriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing esomeprazole and naproxen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing esomeprazole and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Esomeprazole and naproxen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen and sumatriptan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only lansoprazole and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Misoprostol and naproxen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen and sumatriptan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only naproxen in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only esomeprazole and naproxen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naproxen (as naproxen sodium) 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]